Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neoplasms, Germ Cell and Embryonal × Paclitaxel × Clear all

Phase

Status

Sponsor Class

OTHER 5 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Esophageal Neoplasms 7 Breast Neoplasms 6 Stomach Neoplasms 4 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thymoma 1 Small Cell Lung Carcinoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1 Carcinoma, Ovarian Epithelial 1 Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1

Interventions

Cisplatin 2 avelumab 1 Paclitaxel 1 Ifosfamide 1 Everolimus 1 Disulfiram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02414685 2020-08-07

TIP

National Cancer Institute, Slovakia

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡